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Abstract The glymphatic system is a brain-wide clearance pathway; its impairment contributes
to the accumulation of amyloid-b. Influx of cerebrospinal fluid (CSF) depends upon the expression
and perivascular localization of the astroglial water channel aquaporin-4 (AQP4). Prompted by a
recent failure to find an effect of Aqp4 knock-out (KO) on CSF and interstitial fluid (ISF) tracer
transport, five groups re-examined the importance of AQP4 in glymphatic transport. We concur
that CSF influx is higher in wild-type mice than in four different Aqp4 KO lines and in one line that
lacks perivascular AQP4 (Snta1 KO). Meta-analysis of all studies demonstrated a significant
decrease in tracer transport in KO mice and rats compared to controls. Meta-regression indicated
that anesthesia, age, and tracer delivery explain the opposing results. We also report that
intrastriatal injections suppress glymphatic function. This validates the role of AQP4 and shows that
glymphatic studies must avoid the use of invasive procedures.
DOI: https://doi.org/10.7554/eLife.40070.001
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Introduction
A brain-wide fluid transport pathway, known as the glymphatic system, supports the rapid exchange
of cerebrospinal fluid (CSF) and interstitial fluid (ISF) along perivascular pathways (Iliff et al., 2012).
The glymphatic system consists of three principal sequential anatomic segments: (i) CSF inflow along
the perivascular spaces surrounding penetrating arteries, (ii) dispersion of CSF through the wider
interstitium, and (iii) efflux of ISF along the large-caliber draining veins to re-enter the CSF within the
ventricular and cisternal compartments (Jessen et al., 2015). Ultimately, interstitial solutes cleared
to the CSF exit the brain through meningeal lymphatic vessels flanking the venous sinuses, along cra-
nial and spinal nerve sheathes, and across the cribriform plate (Louveau et al., 2015;
Aspelund et al., 2015). Astrocytic endfeet ensheath the cerebral vasculature, and the abundantly
expressed astroglial water channel aquaporin-4 (AQP4) localizes primarily to the perivascular end-
foot membrane domain abutting the basal lamina. As this anatomic arrangement provides a route
for rapid water movement between the perivascular space and the glial syncytium, AQP4 has been
proposed to support perivascular fluid and solute movement along the glymphatic system
(Nedergaard, 2013).
Several groups have independently shown that the astrocytic AQP4 is essential for fast glym-
phatic transport. Iliff et al. demonstrated a significant suppression of both perivascular CSF tracer
influx and interstitial mannitol and amyloid-b (Ab) clearance in Aqp4 knockout (KO) mice (Iliff et al.,
2012). Subsequent work demonstrated that Aqp4 gene deletion exacerbated glymphatic pathway
dysfunction after traumatic brain injury (TBI) and promoted the development of neurofibrillary
pathology and neurodegeneration in the post-traumatic brain (Iliff et al., 2014). Plog et al. similarly
found that Aqp4 KO mice exhibit slowed transport of interstitial solutes to the blood after TBI,
reflected by a significant reduction in plasma biomarkers of TBI, including GFAP, neuron-specific
enolase, and S100b (Plog et al., 2015). Xu et al. reported that deletion of Aqp4 exacerbated Ab pla-
que accumulation and cerebral amyloid angiopathy in the APP/PS1 murine model of Alzheimer’s dis-
ease (Xu et al., 2015). Achariyar et al. found significantly reduced distribution of FITC-ApoE3, 125I-
apoE2, 125I-apoE3, 125I-apoE4, as well as 14C-inulin in Aqp4 KO mice following tracer injection to the
CSF (Achariyar et al., 2016). Lundgaard et al. reported that glymphatic clearance of lactate was
reduced in Aqp4 KO mice (Lundgaard, 2016). Finally, Murlidharan et al. demonstrated that Aqp4
KO mice exhibit significantly impaired clearance of adeno-associated viruses (AAV) infused into the
ventricles, and concluded that glymphatic transport profoundly affects various aspects of AAV gene
transfer in the CNS (Murlidharan et al., 2016). A recent MRI study showed the AQP4 facilitator,
TGN-073, potentiated the transport of interstitial fluid from the glia limitans externa to pericapillary
Virchow-Robin space (Huber et al., 2018).
The critical role of AQP4 in supporting perivascular CSF-ISF exchange was recently questioned in
a report by Smith et al. (2017), in which the authors failed to detect any reduction in CSF tracer
influx into the brain parenchyma of Aqp4 KO mice compared to wild-type (WT) controls. Because a
key element of the glymphatic hypothesis is the role of astroglial water transport in supporting peri-
vascular CSF-ISF exchange, we consider it critical to re-examine the role of AQP4 in this process,
with an aim to resolve the discrepant reports. Using data generated from five independent laborato-
ries, we have undertaken such a re-evaluation of the effects of Aqp4 deletion on perivascular glym-
phatic exchange. Results of this analysis consistently confirm that Aqp4 deletion impaired
perivascular glymphatic flow relative to that in wild-type mice. Our conclusion is strengthened by the
use of four independently generated Aqp4 KO lines, including the line used by Smith et al. (2017),
as well as the a-syntrophin (Snta1) KO line, which lacks AQP4 perivascular localization despite nor-
mal expression levels (Amiry-Moghaddam et al., 2003).
Smith et al. (2017) also questioned the existence of tissue bulk flow based injecting tracers of
varying molecular sizes into cortex or striatum. We questioned this approach based on the prior find-
ing that traumatic brain injury is linked to an immediated and sustained reduction in CSF influx
(Iliff et al., 2014). As expected, our analysis showed that insertion of glass pipettes into the brain
markedly reduced brain-wide CSF tracer influx. Thus, interstitial fluid transport should not be studied
following invasive procedures in the brain.
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Results
The study included data from five laboratories using four independently generated Aqp4 KO lines
and one Snta1 KO mouse line (Figure 1a–e) (Fan et al., 2005; Ikeshima-Kataoka et al., 2013;
Ma et al., 1997; Thrane et al., 2011; Adams et al., 2000). Immunohistochemistry done in parallel
with the glymphatic experiments verified that AQP4 was indeed deleted in all the Aqp4 KO mouse
lines (Figure 1a–c and e). In the Snta1 KO mice, immunofluorescence demonstrated that perivascu-
lar AQP4 polarization was absent in this line (Figure 1d).
NMU: reduced influx of a fluorescent CSF tracer in Aqp4 KO mice
We injected the fluorescent tracer Texas Red-dextran (3 kD, TRd3) intracisternally, as previously
described (Iliff et al., 2012). We first compared overall penetration of TRd3 into the dorsal and ven-
tral surfaces of the whole-brain between WT and Aqp4 KO (Aqp4-/-) mice using ex vivo near infrared
fluorescence imaging. Quantification of the mean integrated optical density (MIOD) of TRd3 on the
dorsal and ventral brain surface along anterior-posterior position of bregma showed a significant
reduction in Aqp4 KO mice compared with WT mice (Figure 2a–c). Interestingly, CSF tracer entry
into the ventral brain was higher than into the dorsal brain. We also compared penetration of TRd3
into the brain on the serial coronal forebrain slides (+1.7 to  0.7 mm from bregma) between the
two genotypes. The percentage area of whole-slice fluorescence was significantly reduced in Aqp4
KO mice compared to WT controls (Figure 2d,f). Subregional quantification on the coronal section
at the level of 0.5 mm anterior to the bregma showed that penetration of CSF tracer was high in the
ventral and lateral brain surface of WT mice, but was comparable in the dorsal surface of the brain
with Aqp4 KO mice (Figure 2g–h), further supporting difference in brain regions of CSF tracer influx.
Specifically, Aqp4 KO markedly impaired the influx of TR-d3 into both the perivascular space and
the brain parenchyma in the hypothalamus, one of the brain regions with the highest expression of
AQP4 (Fan et al., 2005; Nielsen et al., 1997) (Figure 2e). Quantification of the intensity of TR-d3 as
a function of the distance from the brain surface showed rapid decay of tracer with increasing dis-
tance from the ventral surface of the hypothalamus in Aqp4 KO mice. The tracer was almost unde-
tectable at 500 mm below the brain surface in both the perivascular space and in the brain
parenchyma in Aqp4 KO mice. By contrast, the TR-d3 fluorescence intensity remained at 90% of the
pial surface intensity to a depth of 500 mm in the perivascular space as well as in the adjacent paren-
chyma in WT mice (Figure 2i–j). Taken together, these results replicate the previous finding that
AQP4 facilitates the transfer of intracisternally injected TR-d3 from the CSF into the parenchyma
(Iliff et al., 2012).
RIKEN: histological enhancement of CSF tracer reveals compromised
parenchymal tracer infiltration in Aqp4 KO mice
The RIKEN and Keio group used another strain of Aqp4 KO mice, in which the exon 1 of Aqp4 is
replaced with eGFP. In this experiment, biotinylated dextran amine (BDA, 0.5%, 70 kDa) was
injected under deep ketamine-xylazine (KX) anesthesia (Figure 3a). Because Aqp4 KO mice express
eGFP, we used Alexa 594-conjugated streptavidin (SA) to visualize BDA. This approach has an
advantage that BDA signals are amplified by the histological processing and clearly distinguished
from intrinsic fluorescence (i.e. before histological processing). As a result, BDA distribution
appeared less extensive in the cortex of Aqp4 KO mice (Figure 3b). Quantification of SA-enhanced
BDA signals in the cortical parenchyma showed depth-dependent profiles that decayed with cortical
depth after the initial peak for both wild type and Aqp4 KO mice. Notably, BDA signals in the cortex
of Aqp4 KO mice are of lower intensity and penetrated less into the parenchyma at an anterior-pos-
terior position of bregma (Figure 3c). Next, we examined if the compromised BDA penetration in
Aqp4 KO mice is generally observed across the anterior-posterior extent of the cortex. Indeed,
Figure 3d shows that BDA distribution in Aqp4 KO cortex is broadly compromised.
UNC: CSF tracer influx is decreased in Aqp4 KO mice compared to
background strain controls and wild-type mice
We assessed the reproducibility of the experiments performed in Smith et al. (2017) by using the
same Aqp4 KO mouse line but employing the original methodology reported by Iliff et al. (2012).
In order to determine if the background strains of the different Aqp4 KO lines have an effect on CSF
Mestre et al. eLife 2018;7:e40070. DOI: https://doi.org/10.7554/eLife.40070 3 of 31
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Figure 1. Strategy used for generation of KO mice and the experimental design of the study. Top row of each panel represents the institution where
the line originated from and the strategy used to generate the four global Aqp4 KO mice and the Snta1 KO mice. Second row of each panel shows the
five labs that collected data on glymphatic system function in the five transgenic mouse lines: (a) Nanjing Medical University (NMU), (b) RIKEN Center
Figure 1 continued on next page
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inflow, we included both CD1 and C57BL/6 controls. We compared the intraparenchymal entry of
Alexa Fluor 647-conjugated bovine serum albumin (66 kDa, BSA-647) delivered into cisterna magna
of ketamine/xylazine-anesthetized mice. Thirty minutes after the injection, the brains were harvested,
and tracer distribution evaluated in coronal sections as described previously (Iliff et al., 2012).
Parenchymal distribution of tracer showed a significant reduction in Aqp4 KO mice compared with
both CD1 mice (Aqp4+/+) and wild-type C57BL/6 (WT) mice (Figure 4a–b). No significant difference
in global tracer influx was seen between the two control groups. To evaluate if CSF influx was glob-
ally decreased or only limited to a particular brain region, we analyzed sections at different anterior-
posterior coordinates as analyzed in Smith et al. (2017) (Figure 4c). Differences in CSF influx
between Aqp4 KO and controls was most notable in coronal sections anterior to bregma
(Figure 4d), perhaps reflecting that these sections include the cortical segment of the middle cere-
bral artery, a main site of CSF influx. Regional quantification showed that this difference was the
result of decreased tracer penetration in the hypothalamus and areas of the basal forebrain
(Figure 4e–f). Interestingly, CSF tracer entry along the ventral and lateral cortex was highest in the
WT compared to the Aqp4+/+ control (Figure 4f) suggesting possible strain-dependent differences.
We conclude that it is possible to replicate the original findings presented in Iliff et al. in the mouse
line reported by Smith et al. when using similar methodology.
URMC: cerebrospinal fluid entry to brain occurs along the glymphatic
pathway and is facilitated by the presence of AQP4 water channels
To evaluate the entry pathways of CSF to the brain we infused Alexa 647-conjugated bovine serum
albumin (BSA) and a Texas Red 3 kDa dextran into the cisterna magna of anesthetized WT and
Aqp4 KO mice. In vivo transcranial optical imaging (Plog et al., 2018) of the far-red BSA-647
showed more CSF influx in the WT compared to the KO (Figure 5a and b). Tracer evidently entered
the brain parenchyma through a network of perivascular spaces of the large cerebral arteries on the
pial surface. More tracer could be found on the dorsal cortical surface of WT mice compared to
Aqp4 KO mice. After 30 min, brains were extracted and immersion-fixed. The tracer distribution was
quantified in coronal sections of both WT and Aqp4 null mice. The KO mice had less influx for both
the 3 kDa dextran and the 66 kDa BSA compared to the WT (~32.7% and ~47.06%, respectively),
despite the 22x difference in molecular weight (Figure 5c–e). In a replicate experiment where the
injection volume and injection rate was half of the previous, Aqp4 deletion also reduced CSF entry
through the glymphatic pathway by ~42.4% (Figure 5f and g). The relative suppression of CSF tracer
influx observed is comparable across previously reported findings, despite use of different tracer
molecules and injection paradigms (Iliff et al., 2012). The depth of tracer penetration from the corti-
cal surface was quantified using a similar approach to that reported in Smith et al. (2017) (Figure 5f
and h). Tracer penetration into brain was found to be ~2 fold higher in the WT than in the KO
mice (Figure 5i). To ensure that the mice were in fact knockouts, mice were genotyped using qPCR
for both the Aqp4 locus (Figure 5j) and the excision sequence (Figure 5k). The results confirmed
that all mice were either homozygous for the Aqp4 locus (Aqp4+/+) or were homozygous knockouts
(Aqp4-/-) possessing no copies of exon 1–3 of the Aqp4 gene.
OHSU: reduced glymphatic CSF influx in Snta1 KO mice with loss of
polarized expression of AQP4 in vascular endfeet of astrocytes
To assess the role of perivascular astrocytic localization of AQP4 in mediating CSF flux into the brain
parenchyma, we utilized the Snta1 KO mouse line. These mice lack expression of the adaptor protein
Figure 1 continued
for Brain Science (RIKEN), (c) University of North Carolina (UNC), (d) Oregon Health and Science University (OHSU), (e) University of Rochester Medical
Center (URMC). (a-e) Immunohistochemical analysis showing the lack of AQP4 expression in the global KOs and (d) lack of perivascular AQP4
localization in Snta1 KO compared to WT mice. Scale bar: 50 mm. (a-e) Third row displays the volume and rate used for the intracisterna magna (CM)
injections for each experiment, the tracer used, and the experiment duration. Note that URMC collected two full data sets using an injection rate of
either 1 or 2 ml/min. (a-e) The last row display the analyses strategy employed by each of the five research group in Figures 2–6. (f) Additional
experiments performed in Figure 7 tested the effect of intrastriatal (IS) injection on global glymphatic function. TxRd, Texas Red; BDA, biotinylated
dextran amine; BSA-647, bovine serum albumin-Alexa Fluor 647; DCE-MRI, dynamic contrast-enhanced magnetic resonance imaging.
DOI: https://doi.org/10.7554/eLife.40070.002
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Figure 2. NMU: Aqp4 gene deletion reduced the penetration of intracisternally injected tracer into the brain parenchyma. Texas Red-conjugated
dextran (TRd3, 3kD) was injected intracisternally into WT and Aqp4 KO mice. Thirty minutes after injection, the anesthetized animals were perfusion
fixed, and the fluorescence was evaluated ex vivo. (a) Representative near infrared (NIR) fluorescence images of the dorsal and ventral whole-brains of
four mice per genotype. (b-c) Quantification of the mean integrated optical density (MIOD) of TRd3 on the dorsal (b) and ventral (c) brain surface of WT
(grey) and Aqp4 KO (purple) mice from 4.0 mm anterior to 8.0 mm posterior to bregma. (d) Representative images of coronal brain sections at +0.5 mm
Figure 2 continued on next page
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a-syntrophin, which links AQP4 to the dystrophin associated complex and is critical for maintenance
of the perivascular localization of AQP4 (Jessen et al., 2015). Immunolabeling of AQP4 illustrates
the loss of AQP4 perivascular localization in the Snta1 KO mice (Figure 6a–b). Higher magnification
imaging reveals that, while perivascular localization is lost, widespread AQP4 expression is still
detectable by immunofluorescence, consistent with a previous characterization of the mouse line
Figure 2 continued
from bregma from five pairs of WT and Aqp4 KO mice showing TRd3 distribution within the brain. (e) High magnification micrographs of the
hypothalamus (lined area in d) showing the fluorescence intensity of TRd3 within the perivascular space (star) and adjacent brain parenchyma (dotted
line) of WT mice and Aqp4 KO mice, respectively. (f) Quantification of the percentage area of whole-slice fluorescence of the both genotypes for 6–8
forebrain sections (+1.7 to  0.7 mm from bregma) of each mouse. (g) Diagram showing the subregional analysis of brain sections at the level of 0.5 mm
anterior to bregma. (h) Quantification of the mean fluorescence intensity (AU, arbitrary units) of TRd3 of the dorsal, ventral and lateral brain regions,
respectively. (i-j) Quantification of the mean fluorescence intensity of TRd3 along the perivascular space and the interstitium adjacent to the vessels
under the ventral surface of the hypothalamus of the both genotypes. Shades and error bars represent standard deviation. Data in Figure 2b and c
were analyzed by repeated-measures ANOVA, N = 4 per group. Data in Figure 2f,h,i and j were analyzed by Student’s t-test. p-Values shown are
comparisons between WT and Aqp4-/-. ns: not significant (Figure 2—source data 1).
DOI: https://doi.org/10.7554/eLife.40070.003
The following source data is available for figure 2:
Source data 1. Source data for Figure 2.
DOI: https://doi.org/10.7554/eLife.40070.004
Figure 3. RIKEN: Aqp4 -/- mice display compromised CSF tracer infiltration under ketamine-xylazine anesthesia. (a) Schematic diagram for CM injection
of BDA tracer (left) and experiment schedule (right). (b) Examples of SA-enhanced BDA distribution 30 min after CM injection. Slices at an anterior-
posterior position of bregma are presented for WT (upper) and Aqp4-/- (lower) mice. Depth profile is calculated for the cortical position 3 mm lateral to
the midline. (c) Mean depth profiles of SA-enhanced BDA signals for WT (black, N = 4) and Aqp4-/- (green, N = 9) mice. (d) Mean SA-enhanced BDA
signal intensities (3 mm lateral to the midline, depths 0–800 mm) along anterior-posterior positions for WT (black) and Aqp4-/- (green) mice. Shades and
error bars represent SEM. *p < 0.05, **p < 0.01, t-test (Figure 3—source data 1).
DOI: https://doi.org/10.7554/eLife.40070.005
The following source data is available for figure 3:
Source data 1. Source data for Figure 3.
DOI: https://doi.org/10.7554/eLife.40070.006
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(Figure 6a–b insets (Neely et al., 2001)). We next sought to determine if parenchymal CSF influx
kinetics are altered when perivascular AQP4 localization is lost. Here, we used dynamic contrast-
enhanced magnetic resonance imaging (DCE-MRI) to measure the influx of the contrast agent gado-
teridol (Gad) into brain parenchyma after intracisternal injection. We performed serial T1-weighted
imaging at 10 min intervals following administration of the contrast agent (Figure 6c–h). At 30 min
after the start of the injection, elevated levels of Gad were detected in both WT mice and Snta1 KO
mice, particularly along the ventral surface of the brain (Figure 6e–f), but by 60 min Gad signal
within the parenchyma of Snta1 KO mice was significantly reduced compared to wild type mice
(Figure 6g,h,n). Regional assessment revealed decreased signal in Snta1 KO mice across brain
regions, which was most pronounced in cortex and hippocampus compared to subcortical brain
regions and within the ventricles (Figure 6j–m). Taken together, these data illustrate a role for a-syn-
trophin in facilitating CSF-ISF exchange and, by extension, support the reported role of AQP4 in this
process. Furthermore, these results suggest that the perivascular localization of AQP4 contributes to
the kinetics of CSF influx into the brain parenchyma.
Figure 4. UNC: CSF tracer influx is decreased in Aqp4 KO mice. (a) Coronal sections from a C57BL/6 wild-type mouse (WT), CD1 background strain
control (Aqp4+/+), and Aqp4 KO mice (Aqp4-/-) showing a fluorescent CSF tracer, BSA-647 and co-labeling with DAPI. Scale bar: 1 mm (b) Mean pixel
intensity in arbitrary units (A.U.) for six brain sections of each mouse for all three groups. n = 3 (WT), 7 (Aqp4+/+), 6 (Aqp4-/-). One-way ANOVA Tukey’s
multiple comparisons test, Interaction term: p = 0.0110, F = 6.512, ns: not significant. (c) Diagram showing the anterior-posterior range of the quantified
coronal sections relative to bregma from (b). (d) Quantification of the slices shown in (c) + 1.2 to  1.8 mm from bregma. Repeated measures two-way
ANOVA with Tukey’s multiple comparisons test, Interaction term: p = 0.038, F = 2.085, p values shown are comparisons of WT and Aqp4+/+ vs. Aqp4-/-.
(e) Diagram depicting the ROIs included in the regional analysis of brain slices at +0.6 mm from bregma. CPu: caudoputamen; HT: hypothalamus; BF:
basal forebrain; DC: dorsal cortex; LC: lateral cortex; VC: ventral cortex. (f) Mean pixel intensity of brain regions shown in (e) for coronal sections + 0.6
mm from bregma. Repeated measures two-way ANOVA Tukey’s multiple comparisons test, Interaction term: p < 0.0001, F = 8.109. Data is presented
as mean ±SEM (Figure 4—source data 1).
DOI: https://doi.org/10.7554/eLife.40070.007
The following source data is available for figure 4:
Source data 1. Source data for Figure 4.
DOI: https://doi.org/10.7554/eLife.40070.008
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Insertion of an injection pipette in striatum is linked to a global
suppression of CSF influx
Smith et al. (2017) questioned the existence of bulk flow within the brain parenchyma based on
imaging tracer dispersion following local injections in cortex or striatum. The tracers were delivered
by glass pipettes inserted through a cranial burr hole. The surgical procedure associated with inser-
tion of glass pipettes is obviously traumatic. Since acute and chronic traumatic injury markedly
Figure 5. URMC: Glymphatic influx of CSF tracer is facilitated by AQP4. (a) Representative images from an in vivo transcranial optical imaging
experiment of a WT control mice (Aqp4+/+) and Aqp4 KO (Aqp4-/-) mice starting at 15 min after intracisternal delivery of 10 ml (2 ml/min) of a 66 kDa
fluorescent tracer, BSA-647. Scale bar: 2 mm. (b) Mean pixel intensity (MPI) of BSA-647 over a 30 min experiment, imaging was started at the beginning
of the injection. Two-way repeated measures ANOVA with Sidak’s multiple comparisons test, overall model *p = 0.0329, multiple comparisons
*p < 0.05; n = 6–7/group. (c) Coronal sections collected 30 min after intracisternal injection of two varying molecular size tracers, 3 kDa Texas Red
dextran and BSA-647. Mean pixel intensity for a (d) 3 kDa dextran and (e) BSA from six coronal sections between +1.2 and  1.8 mm from bregma for
each animal. Two-tailed unpaired t-test, **p = 0.0097, ****p < 0.0001; n = 6–8/group. (f) Coronal section from an Aqp4+/+ mouse stained and imaged
for AQP4 (magenta) and BSA-647 tracer (cyan). (g) Mean pixel intensity from a replicate experiment quantified the same as (e). Two-tailed unpaired
t-test, *p = 0.0335, n = 4–6/group. (h) Mean tracer penetration depth profiles normalized to the fluorescence at the pial surface of a coronal section at
bregma from the set of experiments displayed in (g). The line was placed orthogonal to the cortical surface at the most dorsal position where tracer
could be found at the pial surface (f). Tracer depth in the WT mice was measured at the same position as the KO mouse. Two-way repeated measures
ANOVA with Sidak’s multiple comparisons test, overall model ****p < 0.0001, multiple comparisons ****p < 0.0001, n = 4–6/group. (i) Cortical depth at
which the fluorescence at the surface decreases by half for the profiles in (h). Two-tailed unpaired t-test, *p = 0.0161, n = 4–6/group. (j) Relative copy
numbers (RCN) of the Aqp4 gene locus and the excision sequence (k) showing successful deletion of Aqp4 exon 1–3. RCN was quantified by qPCR for
mice used in the experiment in (g). Data expressed as mean ±SEM (Figure 5—source data 1).
DOI: https://doi.org/10.7554/eLife.40070.009
The following source data is available for figure 5:
Source data 1. Source data for Figure 5.
DOI: https://doi.org/10.7554/eLife.40070.010
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Figure 6. Deletion of the adapter protein a-syntrophin impairs AQP4 perivascular localization, and CSF influx into the brain parenchyma. Dynamic
contrast enhanced magnetic resonance imaging (DCE-MRI) was acquired on a 11.75 preclinical MRI scanner, and was used to characterize the effect of
a-syntrophin deletion on gaditeridol influx into the brain. Representative images of AQP4 perivascular localization in wild-type mice (a), and the loss of
perivascular localization of AQP4 seen in the Snta1-/- mice (b). Scale bar: 50 mm, inset scale bar: 10 mm. (c-h) Coronal slice of T1-weighted images
Figure 6 continued on next page
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suppress CSF influx (Iliff et al., 2014), we questioned the validity of studying interstitial tracer dis-
persion using an invasive approach. To this end, we compared CSF tracer (BSA-647, 66 kDa) influx in
three groups of mice anesthetized with KX: (i) controls with no surgery beyond CM injection, (ii)
insertion of a glass pipette (12 mm diameter tip) and injection of 20 nl (4 nl/min) HiLyte 488-amyloid-
b1-40 in aCSF, or (iii) same as group two but HiLyte 488-amyloid-b1-40 was not added to the 20 nl
aCSF (Figure 1f). One hour later, the BSA-647 tracer was injected into cisterna magna and allowed
to circulate for 1 hr before the brain was harvested, immersion-fixed, and the distribution of BSA-
647 analyzed in coronal brain sections (Figure 7a–b). The analysis showed that the two groups
exposed to invasive surgery exhibited markedly suppressed CSF tracer influx compared with the
control group (Figure 7c). The suppression of CSF tracer influx in animals with insertion of the glass
pipettes was symmetric with no difference in tracer influx between the ipsilateral and the contralat-
eral hemisphere (p > 0.05, 3–5 slices per animal, n = 7, Wilcoxon rank-sum test). These observations
Figure 6 continued
acquired by DCE-MRI demonstrate the reduced influx of gaditeridol contrast agent into the parenchyma in Snta1-/- mice relative to wild-type mice at 30
and 60 min. Scale bar: 1 mm. (i-n) Quantification of T1 weighted signal in various brain subregions normalized to baseline at each time point. Traces for
each individual animal are presented (lines) along with the summary statistics (mean ±SEM, two-way ANOVA). WT n = 5, ASYNKO n = 7. CTx = cortex
(p = 0.0035) Hip = hippocampus (p = 0.0003) Subcortical = subcortical regions (p = 0.0185) 3V = 3rd Ventricle (p = 0.0284) Total (p = 0.0085) (Figure 6—
source data 1).
DOI: https://doi.org/10.7554/eLife.40070.011
The following source data is available for figure 6:
Source data 1. Source data for Figure 6.
DOI: https://doi.org/10.7554/eLife.40070.012
Figure 7. A unilateral intrastriatal injection reduces global glymphatic function. (a) KX-anesthesized mice received
an injection into striatum. After injection, the glass capillary was slowly removed and the skull sealed with silicone
elastomer. One hour later, mice received an intracisternal injection of a 66 kDa BSA-647 tracer and brains were
removed and drop fixed 60 min later. (b) Control mice only received the intracisternal injection but not the
intrastriatal injection. Mice that received an intrastriatal injection were injected with either HiLyte 488-amyloid-b1-40
or an aCSF sham. (c) Global glymphatic tracer influx was quantified from a total of six coronal sections
between +1.2 and  1.8 mm from bregma for each animal. Ordinary one-way ANOVA posthoc Tukey’s multiple
comparisons test, Control vs. Ab-injected: ***p = 0.0006; Control vs. Sham: ***p = 0.0001; n = 6–8/group
(Figure 7—source data 1).
DOI: https://doi.org/10.7554/eLife.40070.013
The following source data is available for figure 7:
Source data 1. Source data for Figure 7.
DOI: https://doi.org/10.7554/eLife.40070.014
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show that invasive procedures acutely suppresses brain-wide CSF influx and that tracer injection
should not be used in the study of the glymphatic system.
Meta-analysis
A potential cause of conflicting results could be due to varying methodology used in each study. We
used meta-analysis to evaluate this heterogeneity and better understand the relationship between
AQP4 and CSF-ISF transport using all of the available literature that evaluated tracer injections in
global Aqp4 KO and wild-type mice. Studies were largely divided into two types: 1) intracisternal
and 2) intracerebral tracer injections (Figure 8a–b), a separate meta-analysis was conducted for each
of these two main experimental approaches.
CSF influx
The search for studies that delivered tracers into the cisterna magna to evaluate CSF entry yielded a
total of 13 eligible independent datasets from six different laboratories (Supplementary file 1).
Experiments were done in a total of 144 mice (92.4%) and rats (7.6%) from five different Aqp4 KO
lines (UIO: 50.7%; UCSF mouse: 25.7%; RIKEN: 9.03%, UCSF rat: 7.64%, and NMU: 6.94%) with a
wide age range (6–24 weeks), the age of the rat line was not reported. Results were obtained using
three different anesthetic protocols (ketamine/xylazine: 68.8%; tribromoethanol: 24.3%; chloral
hydrate: 6.94%) and it was not possible to determine sex due to variable reporting. Experiments
consisted of the delivery of fluorescently- (86.1%) and radioisotope-labeled (13.9%) tracers that
ranged in size (4.5–70 kDa) and concentration. Tracer delivery varied in total volume (5–10 ml) and
the injection rate (1–2 ml/min) while experiment duration ranged from 15 to 30 min. Standardized
mean differences (SMD) were used in the meta-analysis to account for different outcome measures
(e.g. fluorescence intensity, thresholded area, % injected radiation), and demonstrated a significant
overall decrease in tracer entry in Aqp4 KO mice compared to controls (SMD with 95% confidence
interval:  1.70 [ 2.49;  0.90]; p<0.0001) with a high degree of interstudy heterogeneity
(I2 = 73.1%; p<0.0001; Figure 8a). Leave-one-out and meta-regression sensitivity analyses were
used to explore the sources of heterogeneity. As expected based on the direction and magnitude of
the effect estimates reported in the studies, the high degree of heterogeneity was primarily caused
by three datasets extracted from Smith et al. We could not confidently determine from the text of
these studies whether these experimental figures were based on separate, independent experi-
ments, or whether they were data collected in the same set of mice. Due to this uncertainty, we con-
ducted leave-one-out analyses that would recapitulate all possible scenarios. The analysis showed
that when these data sets were excluded, there was a reduction in heterogeneity (I2 = 65.7%, 70.3%,
and 71.4%; p = 0.0007, p = 0.0001 and p < 0.0001). When all three data sets from this publication
were excluded, the heterogeneity becomes non-significant (I2 = 0.0%, p = 0.4622). Due to the rele-
vance of this study, we included all data sets in the final results reported (Supplementary file 1).
Using meta-regression to further explore sources of heterogeneity, we tested whether the: KO line,
age, anesthesia type, tracer properties, injection paradigm, experiment duration, and detection
method were significant covariates (Supplementary file 1). The KO line used (p = 0.0001, Test of
Moderators), the age of the mice (p = 0.0006), the anesthetic protocol (p < 0.0001), and the injec-
tion rate (p < 0.0001) explained a significant proportion of the observed variance between the data-
sets. The variables that explained the largest proportion of heterogeneity were anesthesia type and
injection rate. The three data sets that reported null results used tribromoethanol (Avertin), an anes-
thetic that was not used in any other studies (all of which found a significant association). The same
three data sets were also the only ones to report variable injection rates (10 ml delivered over 5–7
min) in comparison with the remaining studies that used exact injection rates. Thus, it is possible that
the choice of anesthesia type and injection rate could explain the heterogeneity. Animal age was
also a significant source of heterogeneity, accounting for 85.28% of the variance between studies.
This may be in part explained by the fact that two out of the three data sets that demonstrated no
association were completed in mice that were older than the mice used in the majority of other stud-
ies and reported the largest age range (12–24 weeks). Although it is not possible to determine the
exact role that these covariates played in the observed results, both anesthesia and aging have been
shown to modify the degree of intracisternal tracer entry, providing another potential explanation
for the observed heterogeneity (Benveniste et al., 2017; Kress et al., 2014). Similarly, the
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heterogeneity stemming from the KO line may also be explained by the fact that the majority of
UCSF KO mice (72.9%) were in the null studies. Interestingly, the fourth study (UNC, this report) that
utilized the UCSF KO mouse line, but an alternate anesthetic (ketamine/xylazine) observed a signifi-
cant effect. Unfortunately, due to low study number we were unable to include two covariates (e.g.
anesthesia type and KO line) in the meta-regression to test this interaction. Additional covariates
including tracer properties, the injection paradigm, and the detection method were not significant
sources of heterogeneity suggesting that multiple experimental methodologies should be able to
observe an effect between KO and control.
Figure 8. Evidence evaluating the role of AQP4 in CSF influx and ISF efflux. (a) Meta-analysis from experiments
that delivered either fluorescence- or radio-labeled tracers into the cisterna magna of both Aqp4 KO and wild-
type rodents. (b) Meta-analysis from studies that delivered intracerebral tracers to evaluate clearance or transport
of tracers out of the brain. p-Value is from the overall random effects model. Data in forest plots presented as
standardized mean difference (SMD) with a 95% confidence interval (CI). Th: thalamus; Cn: caudate nucleus.
DOI: https://doi.org/10.7554/eLife.40070.015
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ISF efflux
There were nine eligible studies produced by four independent research groups that injected tracers
or contrast agents into the brain of Aqp4 KO or wild-type rodents in order to evaluate brain clear-
ance or ISF efflux (Supplementary file 2). These experiments were conducted in a total of 87
rodents from both mouse (72.4%) and rat (27.6%) KO lines. There were two murine lines (UIO:
57.5%; UCSF: 14.9%) and one rat line (Beijing: 27.6%) generated by three separate groups. Age of
the mouse lines ranged broadly (0–24 weeks), while the age of the rat line could not be confirmed
but a weight range of 250–300 g was reported. Four anesthetic protocols were used for these
experiments (ketamine/xylazine: 57.5%; hypothermia: 6.9%; tribromoethanol: 8.0%; sodium pento-
barbital: 27.6%). Fluorescence-conjugated tracers (14.9%), radio-labeled (57.5%) tracers, and gado-
linium-based contrast agents (27.6%) that ranged in size (0.18–45 kDa), concentration, and where
they were delivered within the brain (striatum: 40.2%; cortex: 39.1%; thalamus: 13.8%; lateral ventri-
cle: 6.9%). Tracer delivery varied in total volume (0.02–3 ml) and injection rate (0.017–3 ml/min), differ-
ing based on the injection site or whether the experiment was done in mice or rats. Experiment
durations ranged between 45 and 240 min and one of the studies (Smith et al.) did not report this.
Results from the overall meta-analysis showed a significant decrease in the transport of the injected
substance in Aqp4 KO mice relative to controls ( 1.88 [-2.88;  0.87]; p = 0.0003) with high hetero-
geneity (I2 = 70.0%, p = 0.0008; Figure 8b). Similar to the previous model, leave-one-out analysis of
the two null datasets reduced the heterogeneity (I2 = 60.1%; p = 0.0143 and I2 = 65.3%; p = 0.0053,
respectively) and removing both datasets made the heterogeneity non-significant (I2 = 17.2%;
p = 0.299). The same covariates used in the first model were used for meta-regression analysis, in
addition to an injection site variable. Meta-regression was unable to identify significant sources of
heterogeneity; most likely because of two datasets from Teng et al. that found a difference in thala-
mus, but not in striatum, in the same rat line using identical methodology (Teng et al., 2018).
Despite the potential biological significance of this, the study was the only one to use rats, MRI as
the detection method, and had an experiment duration that was 4-fold longer than the other stud-
ies. Therefore, we decided to run a reduced model on all available mouse experiments using fluores-
cence or radioactivity detection methods. The meta-analysis was still highly significant and showed
decreased clearance in the Aqp4 KO mouse lines ( 1.92 [-3.02;  0.82]; p = 0.0006) with a lower
degree of heterogeneity (I2 = 64.1%, p = 0.0103). The KO line used (p = 0.0205), age (p = 0.0075),
the anesthetic protocol (p = 0.0075), the injection rate (p = 0.0056), the experiment duration
(p = 0.0075), and the detection method (p = 0.0205) explained a significant proportion of the
observed variance between the datasets. Similar to previous results, tribromoethanol again seemed
to function as a proxy for the null study from Smith et al. since none of the others used this anes-
thetic. The mouse KO line from UCSF explained a significant proportion of heterogeneity compared
to the other lines, likely because the null dataset accounted for half of the studies that used this line.
Age of the experimental animals was also a significant source of heterogeneity and can be explained
by the wide age range (0–24 weeks) found between the studies but the lack of specific age reporting
could also potentially explain this. Injection rate accounted for the largest proportion of heterogene-
ity in this analysis. The injection rate used by Smith et al. (5  100 ms pulses at 1 Hz and 10 psi), was
highly significant in the meta-regression model compared to the reference injection rate (0.017 ml/
min, p = 0.0007), whereas all other injection paradigms were not significantly different. The Smith
paradigm was therefore the driver of the explanatory value of the injection rate covariate in the
meta-regression model. Similar to anesthesia type, this variable also functioned as a proxy for the
null study since all other datasets reported an exact volumetric injection rate. The reported injection
protocol was used for experiments performed in both mice and rats despite different injection vol-
umes (~20 nl vs. 30,000 nl) suggesting that the rate varied significantly between experiments. The
time the tracer was allowed to circulate after the injection (experiment duration) was also a highly
significant source of variation between studies. The experiment duration that accounted for all the
heterogeneity was the unreported time from the null study. Only one separate study evaluated a
time point that did not report a significant difference between KO and control (30 min; Iliff et al.,
2012). However, this study did report a difference at 60 min after injection, so it is possible that if
Smith et al. used shorter experimental durations this could account for the observed heterogeneity
(Supplementary file 2) (Iliff et al., 2012). The detection method (i.e. fluorescence and radioactivity)
used was also found to be a significant source of heterogeneity. The largest contributor to
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heterogeneity were fluorescent detection methods, mostly likely due to the fact that the study that
obtained a null result used this approach despite most studies using radiolabeled tracers. The
remaining covariates: tracer properties, the injection volume, and the injection site were not signifi-
cant sources of heterogeneity in this analysis.
Discussion
This study evaluated the role of the astrocytic water channel AQP4 in the dispersion of fluorescent
tracers or contrast agents by five independent groups. Four of the groups (NMU, RIKEN, UNC,
URMC) injected CSF tracers in cisterna magna and compared the influx of the tracer in coronal sec-
tions prepared from Aqp4 KO and WT mice, whereas the OHSU group injected contrast agent in cis-
terna magna and then compared CSF transport by DCE-MRI in Snta1 KO and WT mice. Compilation
of data from the six independently-conducted experiments documented that deletion of Aqp4
(Aqp4 KO mice) or mis-localization of AQP4 (through Snta1 gene deletion) suppressed influx of CSF
tracers or contrast agents. In fact, a meta analysis that included all reports published to date came
to the same conclusion (Figure 8). Thus, our observations provide strong and concordant support
for the glymphatic model in which AQP4 supports the perivascular influx of CSF and efflux of ISF
(Iliff et al., 2012). Supporting evidence of this has also been shown in humans; two independent sin-
gle nucleotide polymorphism (SNP) variant association studies identified multiple SNPs in the Aqp4
gene that were associated with cognitive decline in Alzheimer’s disease (AD) and increased Ab bur-
den in humans with reduced sleep quality (Burfeind, 2017; AIBL Research Group et al., 2018). A
separate study by the OHSU group also found that reduced perivascular polarization of AQP4 was a
significant predictor of AD status in postmortem human brains (Zeppenfeld et al., 2017).
Independent replication studies of biological phenomena are essential, both to confirm novel
experimental findings, as well as to extend and refine initial observations and interpretations. The
original report from the URMC group on the glymphatic system showed that deletion of astrocytic
water channels suppressed both the influx of CSF tracers injected into the cisterna magna and the
efflux of tracers infused directly into striatum (Iliff et al., 2012). Follow-up of that finding by the
NMU group documented that Ab accumulation and cerebral amyloid angiopathy were significantly
increased in a double-hit murine model with Aqp4 deletion and Ab over-expression (Xu et al.,
2015). The URMC/OHSU groups subsequently reported that deletion of Aqp4 aggravated neurofi-
brillary pathology following TBI (Iliff et al., 2014), whereas the UNC group showed that deletion of
Aqp4 significantly reduced clearance of AAV (Murlidharan et al., 2016). Thus, these reports concep-
tually address the same idea, although the replications entailed different approaches and methodol-
ogies. The dissenting report from Dr. Verkman’s laboratory belongs to the rarer category of
replication studies, which (as their title states) seeks to test directly the glymphatic hypothesis and
the AQP4-dependence of solute transport in brain. Since their study was intended to gauge the
veracity of the original findings, it should be expected that it follow the experimental design and
data analysis of the original study (Picho et al., 2016), and their methodology should be presented
in sufficient detail to allow the reader to assess the fidelity of their replication (Brandt et al., 2014).
However, Smith et al. (2017) failed to meet these requirements in several key respects. First, their
methodologies deviate from the original report in critical ways. In particular, Iliff et al. used keta-
mine/xylazine (KX) anesthesia rather than tribromoethanol (Avertin) (Iliff et al., 2012). Xylazine is an
a2 adrenergic agonist that blocks release of norepinephrine from the locus coeruleus projections
across the neuraxis. This is an important point, because norepinephrine has been identified as the
key humoral regulator of glymphatic solute transport (Xie et al., 2013), and norepinephrine attenu-
ates glymphatic function. However, with the exception of the photo-bleaching experiments carried
out only in WT mice, Smith et al. (2017) anesthetized their mice with Avertin, an injectable anes-
thetic with an unknown mechanism of action. Avertin is not approved for use in several European
countries and is restricted to terminal procedures in the US (Arras et al., 2001; Meyer and Fish,
2005). The importance of the anesthetic agent in the present context was first highlighted by
Groothuis et al. (2007), who reported that parenchymal solute efflux was 100-fold slower in rats
anesthetized with pentobarbital than those that received ketamine/xylazine. Anesthesia-dependent
effects were also noted by Benveniste et al., that reported a marked difference in influx of contrast
agents in isoflurane-anesthetized animals versus low-dose isoflurane plus dexmedetomidine (an a2
agonist) (Benveniste et al., 2017). The importance of anesthesia is supported by the experiments
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reported here: The UNC group used ketamine/xylazine anesthesia and observed AQP4-dependent
glymphatic transport (Figure 4), despite using the same Aqp4 KO mouse line as in the Smith et al.
(2017). In addition, the methodology of Smith et al. was not presented in sufficient detail to assess
the fidelity of the replication. Key methodological details, such as the injection approach and rate,
anesthesia, or the age of the animals were not provided for data collected in rats. Neither did the
investigators assess whether Aqp4 was deleted in CNS albeit this was the first report utilizing Aqp4
KO rats. In fact, no such data have been published so far to our knowledge (Smith et al., 2017). For
these reasons, the present study is not a replication study of Smith et al. (2017). Instead, we used
the methodology reported in Iliff et al. (2012) and further optimized it in subsequent studies
(Kress et al., 2014; Iliff et al., 2013a).
It is also important to note that the recovery period that follows general anesthesia differs from
the awake state. A recent study reported that increasing anesthesia concentration decreased glym-
phatic function (Gakuba et al., 2018), as opposed to the original finding that the glymphatic system
is maximally active during natural sleep or anesthesia (Xie et al., 2013). However, the recent study
injected CSF tracers under inhalation anesthesia followed by a short recovery period (Gakuba et al.,
2018). This is not a valid approach, because awakening from general anesthesia is associated with
cognitive disturbances (Su et al., 2016; Paredes et al., 2016; Numan et al., 2017) and inhaled anes-
thetics in particular are linked to a high rate of delirium upon emergence from anesthesia
(Brioni et al., 2017). Close evaluation of the imaging in Gakuba et al. shows a failed intracisternal
injection, as enhancement of contrast agent is evident in the paraspinal muscles and extracranial
spaces (Gakuba et al., 2018). In our experience, experimenter error during cisterna magna injec-
tions is a significant source of variability (Xavier et al., 2018). Thus, careful consideration of the
anesthesic regimen and long periods of post-anesthesia recoveries are essential when studying the
glymphatic system.
The initial study articulating the glymphatic model confirmed seminal work by Cserr and col-
leagues that interstitial tracers are cleared from brain tissue at rates that are independent of molecu-
lar weight (Iliff et al., 2012; Cserr et al., 1981). While these early studies support the role of bulk
flow in the clearance of interstitial solutes from the brain interstitium, they lacked the spatial resolu-
tion necessary to resolve whether bulk flow was occurring throughout the entire brain interstitium or
was restricted to a subset of compartments permissive to flow. A large body of indirect experimental
evidence supports the occurrence of bulk flow in the periarterial space in the brain (see reviews by
Hladky and Barrand, 2014 and Nicholson and Hrabeˇtova´, 2017). Smith et al. (2017) themselves
provide such evidence, stating that ’occasionally, when the injected dextran entered the perivascular
space of vessels near the injection site, both large and small dextrans traveled substantial distances
away from the injection site’ (Smith et al., 2017). There is also indirect evidence that this flow is peri-
staltic, propelled by pulsations of the arterial walls (e.g. Hadaczek et al. (2006)). This mechanism
has recently been confirmed by direct observations of pulsatile flow in periarterial spaces
(Bedussi et al., 2018; Mestre et al., 2018). Using two-photon microscopy and particle-tracking
velocimetry, Mestre et al. gathered hundreds of thousands of velocity measurements at sampling
rates up to 30 Hz over half hour experiments, mapping the perivascular flow in space and time in
great detail: their results show that the flow pulses in synchrony with the heartbeat, is driven by pul-
sations of the arterial wall, and produces a net (average) flow in the same direction as the blood
flow. This flow is in accordance with several earlier fluid-dynamic models and experimental studies
(Bilston et al., 2003; Schley et al., 2006; Wang and Olbricht, 2011; Rennels et al., 1985;
Iliff et al., 2013b), and with in vivo dynamic imaging studies, including MRI experiments in human
subjects, demonstrating the rapid distribution of CSF tracers into and through the brain interstitium
along peri-arterial routes (Iliff et al., 2013a; Eide and Ringstad, 2015; Ringstad et al., 2017). In
addition to perivascular spaces, white matter tracts also serve as permissive routes for interstitial sol-
ute and fluid movement (Ohata and Marmarou, 1992; Rosenberg and Kyner, 1980).
As a consequence of the now well-established bulk flow along periarterial spaces, there must be
an outlet for this directional flow: conservation of mass - as expressed by the continuity equation -
demands that this volumetric flow must continue through other parts of the glymphatic system –
that is, in the neuropil and the perivenous spaces. Although the full volumetric net flow must pass
through the neuropil, flow speeds will be lower there because of the much larger total cross-sec-
tional area of the available extracellular flow channels, and due to the availability of the gap junc-
tion-coupled astroglial syncytium as an intracellular route for water and solute
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movement (Asgari et al., 2016). In fact, a meta-analysis that include the more than 200 Aqp4 KO
mice and rats studied so far added further support to the finding that glymphatic influx and efflux
are both highly dependent upon AQP4 expression (Figure 8 , Supplementary file 1 and 2). The
meta-analysis identified the anesthesia protocol, wide age range of the experimental animals and
the injection paradigm are potential causes for the conflicting data reported by Smith et al. How-
ever, it is important to note that glymphatic transport is affected by multiple pathways other than
AQP4. For example, the sleep-wake cycle (Xie et al., 2013), brain injury in the setting of trauma or
ischemia (Iliff et al., 2014; Wang et al., 2017), exercise (He et al., 2017; von Holstein-Rathlou
et al., 2018; Yin et al., 2018), amyloid-b accumulation and acute amyloid-b toxicity (Xu et al., 2015;
Peng et al., 2016), omega-3 fatty acids (Ren et al., 2017), plasma osmolarity (Plog et al., 2018),
and aging (Kress et al., 2014) are important regulators of glymphatic transport. How AQP4 on a
cellular level facilitates CSF-ISF exchange remains to be firmly established. The primary role of AQP
channels is to lower the driving forces for fluid transport across the plasma membranes
(Verkman et al., 2017). AQP4 is highly enriched in astrocytic endfeet facing the perivascular space
and thus strategically positioned to facilitate CSF exchange with interstitial fluid. Accordingly, loss of
the polarized expression of AQP4 in reactive astrocytes lead to a reduction in parenchymal CSF
tracer influx (Iliff et al., 2014; Kress et al., 2014). Moreover, deletion of AQP4 potentiated the
increases in intracranial pressure in a murine model of hydrocephalus consistent with the notion that
AQP4 supports and facilitates intraparenchymal fluid flow (Bloch et al., 2006).
The claim by Smith and Verkman (2018) that solute transport in the parenchyma is primarily
driven by diffusion rather than convection (bulk flow) is based on their finding of a dependence of
this transport on the size of the solute particles. They claim that diffusive transport depends strongly
on particle size, whereas convective transport does not, so long as the ratio of the particle size to
the pore or channel size is less than about 0.5. In support of this claim, they cite a single reference
(Dechadilok and Deen, 2009), which does not actually support their claim, but instead shows a sig-
nificant dependence of flow resistance on particle size for much smaller particles. The influence of
solutes or suspended particles on flow through narrow channels is a complicated problem in hydro-
dynamics, entailing many factors, including solute concentration, electrical charge, shape of the par-
ticle, channel geometry, tortuosity, and possible obstructions (Nicholson and Hrabeˇtova´, 2017).
Hence, it would require a very sophisticated theoretical model to evaluate the role of bulk flow in
the transport observed experimentally by Smith et al. (2017). Their findings are in general agree-
ment with recent modeling studies suggesting that at the smallest microscopic scales, encompassing
small numbers of vessels and the interposed neuropil, diffusion is sufficient to account for observed
solute movement (Asgari et al., 2016; Jin et al., 2016; Holter et al., 2017). However, it is important
to note that these findings do not exclude a contribution of bulk flow within the entire interstitium,
and do not determine whether the experimental approaches used to detect flow on the microscopic
scale are sufficiently sensitive to detect bulk flow occurring at very low flow rates. Also, the majority
of the studies contradicting the glymphatic model are based on theoretical modeling and not exper-
imental evidence (Asgari et al., 2016; Jin et al., 2016; Faghih and Sharp, 2018). We suspected
that the surgical procedures required for intraparenchymal tracer injections utilized in Smith et al.
(2017) might suppress influx of CSF tracers. To formally test this potential caveat, CSF tracer influx
was analyzed in mice in which a glass pipette was inserted in striatum 1 hr earlier (Figure 7). The
analysis showed that insertion of a glass pipette suppressed CSF tracer influx significantly and inde-
pendently of intrastriatal injection of aCSF with or without HiLyte 488-amyloid-b1-40 compared to
non-surgical controls. We conclude that dispersion of tracers in CNS should not be studied using
invasive procedures. Thus, as articulated by Holter et al. in their recent modeling
study (Holter et al., 2017), there is a need to develop more appropriate technical approaches for
evaluating slow interstitial bulk flow over long distances (Ratner et al., 2017), such as DCE-MRI in
nonhuman primates or human subjects. Until then, the glymphatic model of CNS fluid and solute
flow should properly include the rapid exchange of CSF with the brain ISF along perivascular spaces,
with CSF principally entering along peri-arterial spaces and ISF draining towards the ventricular and
CSF compartments along peri-venous pathways and along cranial and spinal nerves, supported by
AQP4-dependent astroglial water transport. On this last element, the present findings from five
independent groups do not concur with the negative findings reported by Smith et al. (2017).
Instead, our compiled data provides strong and consistent support for our claim that solute trans-
port in the rodent brain is facilitated by the polarized expression of AQP4 in astrocytic endfeet.
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Key resources table
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(species)
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Source or
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information
Gene
(Mus musculus)
Aqp4 MGI:107387
Gene
(Mus musculus)
Snta1 NCBI_gene:
20648,
MGI:101772
Strain,
strain background
(Mus musculus)
Aqp4 null/eGFP
knock-in mice
RIKEN BRC RBRC06500;
SJL.Cg-Aqp4<tm1.1(GFP)
Mysi>/MysiRbrc;
CDB0758K-1
Strain,
strain background
(Mus musculus)
Aqp4 knockout
mice
PNAS 108,
846–851
(2011).
PMID: 21187412
OIU
Strain, strain
background
(Mus musculus)
C57BL/6N Beijing Vital River
Laboratory
Animal
Technology
Co., Ltd.
213
Strain, strain
background (Mus
musculus, C57Bl/6J)
male wild type (WT) Jackson
Laboratories,
000664
RRID:IMSR_
JAX:000664
Strain, strain
background
(Mus musculus,
C57BL/6NCrl)
male wild type (WT) Charles River,
027
RRID:IMSR_
CRL:27
Strain, strain
background
(Mus musculus,
C57Bl/6J)
male Snta1-/- Jackson
Laboratories,
012940,
PMID:10995443
RRID:MGI:2181419
Cell line
(Mus musculus)
E14K ES J Neurosci Res.
2005 Nov 15;82
(4):
458–64.
PMID: 16237719
129P2/OlaHsd
Transfected
construct
(Mus musculus)
AQP4 replacement
targeting vector
J Neurosci Res.
2005
Nov 15;82(4):
458–64.
PMID: 16237719
Constructed
using
the positive–
negative
selection
cassettes
derived
from the
vectors
pPolII long neo bpA
and pXhoMC1TK,
containing the neoR
and HSVtk
genes, respectively.
Biological
sample
(Mus musculus)
CD1 blastocysts Beijing Vital River
Laboratory Animal
Technology Co., Ltd.
201
Antibody anti-Aqp4
(rabbit polyclonal)
Sigma A5971,
RRID:AB_258270
(1:1000)
Continued on next page
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Continued
Reagent type
(species)
or resource Designation
Source or
reference Identifiers
Additional
information
Antibody biotinylated-
conjugated
goat anti-rabbit
IgG
(polyclonal)
Vector
Laboratories
BA-1000,
RRID:AB_2313606
(1:200)
Antibody AQP4 (rabbit
primary Ab)
(polyclonal)
Millipore AB3594,
RRID:AB_91530
(1:400–500)
Antibody Alexa Fluor 594
(donkey anti-rabbit
secondary Ab)
(polyclonal)
ThermoFisher A21207,
RRID:AB_141637
(1:500)
Antibody Cy3-conjugated
donkey
anti-rabbit
(polyclonal)
Jackson Immuno
Research
711-165-152,
RRID:AB_2307443
(1:500)
Sequence-
based reagent
oligonucleotide
primers
of Aqp4 and
excision
sequence
Transnetyx Probe ID: Aqp4-2
WT and Aqp4-2 KO
Sequence-
based reagent
oligonucleotide
primers
of Aqp4 and Neo
J Neurosci Res.
2005
Nov 15;82
(4)
:458–64.
PMID: 16237719
AQP4 forward
primer, ACC
ATA AAC TGG
GGT GGC TCA
G; WT AQP4
reverse primer,
TAG AGG ATG
CCG GCT CCA
ATG A; and Neo,
CAC CGC TGA
ATA TGC ATA
AGG CA.
Peptide,
recombinant
protein
Beta - Amyloid
(1 - 40), HiLyte
Fluor 488 - labeled,
Human
Anaspec AS-60491–01 0.5% in aCSF
Commercial
assay or kit
Kwik-Cast World Precision
Instruments
KWIK-CAST
Commercial
assay or kit
Elite ABC Kit Vector
Laboratories
PK-7200
Chemical
compound,
drug
BDA Molecular
Probes/Thermo
Fisher
D1957; BDA-70,000
Chemical
compound,
drug
Alexa-594-conjugated
streptavidin (SA)
Molecular
Probes/Thermo
Fisher
S11227 (1:1000)
Chemical
compound,
drug
Alexa Fluor
647 conjugated
bovine serum albumin
Molecular
Probes/Thermo
Fisher
A34785 0.5–1% in aCSF
Chemical
compound,
drug
Texas Red conjugated
dextran, 3000 MW,
paraformaldehyde,
chloral hydrate
Invitrogen,
Sigma-Aldrich,
Sigma-Aldrich
D3328, 158127, 47335 U
Software,
algorithm
ImageJ software https://imagej.nih.
gov/ij/index.html
RRID:SCR_003070
Software,
algorithm
FIJI RRID:SCR_002285
Continued on next page
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Continued
Reagent type
(species)
or resource Designation
Source or
reference Identifiers
Additional
information
Software,
algorithm
MetaMorph Basic Molecular
Devices
RRID:SCR_002368
Software,
algorithm
Matlab Mathworks RRID:SCR_001622
Software,
algorithm
cellSens Olympus RRID:SCR_016238
Other artificial CSF Sigma-Aldrich All componets
in
ACSF (concentrations
in mM):
126.0 NaCl,
3 KCl, 2 MgSO4,
10.0 dextrose,
26.0 NaHCO3,
1.25 NaH2PO4,
2 CaCl2 are
purchased
from Sigma-
Aldrich
Generation of transgenic mouse lines
NMU
Aqp4 KO mice were generated by Dr. Fan Yan by targeted gene disruption as described previously
(Fan et al., 2005). In brief, an AQP4 replacement targeting vector was constructed using the posi-
tive-negative selection cassettes derived from the vectors pPolII long neo bpA and pXhoMC1TK,
containing the neoR and HSVtk genes, respectively. The targeting construct was linearized with NotI
and introduced into E14K ES cells by electroporation. ES cell clones that were G418/gancyclovir-
resistant were isolated, amplified, and screened for targeting fidelity using Southern blot analysis.
Cells from two targeted clones were microinjected into CD1 blastocysts and implanted into pseudo-
pregnant recipients (Fan et al., 2005). Five-month old Aqp4 KO and WT mice were used in the pres-
ent study.
RIKEN
Aqp4 null/eGFP knock-in mice (SJL.Cg-Aqp4<tm1.1(GFP)Mysi>/MysiRbrc) were generated as
described previously (Ikeshima-Kataoka et al., 2013). Briefly, knockout of AQP4 was accomplished
by replacing the 250 nucleotides in exon 1 (corresponding to the region from Ser 18 to Thr 101)
with eGFP cDNA and a PGK-neomycin cassette flanked by flippase recombination target sequences.
The targeting vector was electroporated into TT2 ES cells derived from a C57BL/6 female and a
CBA male. The PGK-neomycin cassette was removed by crossing with B6-Tg (CAG-FLPe) 37
(Kanki et al., 2006). The resultant mice were backcrossed with the SJL/J strain (Charles River, Japan)
for more than 12 times (RIKEN CDB accession no. CDB0758K-1; http://www.clst.riken.jp/arg/mutant
%20mice%20list.html). Both B6-Tg (CAG-FLPe) 37 and SJL.Cg-Aqp4<tm1.1(GFP)Mysi>/
MysiRbrc >mice are provided by the RIKEN BRC through the National Bio-Resource Project of
MEXT, Japan (accession no. RBRC01835 and RBRC06500, respectively).
UNC
The constitutive Aqp4 KO mouse model was generated by Dr. Alan Verkman (Ma et al., 1997). In
brief, Aqp4 KO mice were generated on a CD1 background, following the construction of a target-
ing vector for homologous recombination of a 7 kb SacI AQP4 genomic fragment, in which part of
the exon one coding sequence was deleted. All animal experiments reported in this study were con-
ducted on Aqp4 KO mice (B6/129), B6/129 controls, and wild-type C57BL/6 mice.
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URMC
Aqp4 KO mice were generated by Dr. Ole Petter Ottersen using GenOway technique, as described
previously (Thrane et al., 2011). Their strategy involved cloning and sequencing of a targeted region
of the murine Aqp4 gene in a 129/Sv genetic background. Identification of a targeted locus of the
Aqp4 gene permitted the delete exons 1–3 to avoid any expression of putative splice variants.
Hence, a flippase recognition target (FRT)-neomycin-FRT-LoxP–validated cassette was inserted
downstream of exon 3, and a LoxP site was inserted upstream of exon 1 (Thrane et al., 2011). The
mice were backcrossed for 20 + generations with C57BL/6N mice prior to experimentation.
OHSU
The Snta1 KO mouse line was generated by Dr. Stanley Froehner (Adams et al., 2000), and was pur-
chased through The Jackson Laboratory (Snta1tm1Scf/J, #012940). In brief, exon 1 of the mouse
Snta1 gene was replaced with a neomycin resistance cassette. The resulting construct was electropo-
rated into 129P2/OlaHsd-derived E14 embryonic, and these cells were then injected into C57BL/6J
blastocysts. The resulting mice were bred with C57BL/6J mice for at least 11 generations before the
colony was established. Adult male and female mice (WT 15.4 ± 1.6 weeks, Snta1 KO 14.7 ± 1.6
weeks) were used in these studies.
Injection, imaging and analysis of CSF tracers or contrast agents
NMU
Intracisternal tracer injections
Intracisternal injections of Texas Red conjugated dextran (TRd3; 3 kDa, Invitrogen) were adapted
from a previous report (Iliff et al., 2012). In brief, the mice were anesthetized by a 4% chloral
hydrate solution. A ten-microliter volume of 0.5% TRd3 dissolved in artificial CSF was infused into
the cisterna magna through a 50 mL syringe mounted with a 27-gauge needle (Hamilton, Reno, NV,
USA), connected to a constant current syringe pump (TJ-2A/L07-2A, Suzhou Wen Hao Chip Technol-
ogy Co. Ltd., Jiangsu, China). The intracisternal injection was carried out at a rate of 2 mL/min. Thirty
min after the start of injection, the still deeply anesthetized animals were perfused trans-cardially
with 4% paraformaldehyde (PFA), and the brains removed and post-fixed in the same fixative for 24
hr.
Tissue processing and image analysis of fluorescent tracer
A subset of WT and Aqp4 KO brains (N = 4 per genotype) were scanned by an ex vivo near infrared
(NIR) fluorescence imaging system (Azure biosystems c600, CA, USA). Briefly, the ventral and dorsal
brains were imaged (excitation length 660 nm, exposure time: 50 ms), as well as the corresponding
bright-field images (Supplementary file 3). The fluorescence and bright-field images were superim-
posed using Adobe Photoshop 8.0. Based on the Mouse Brain Atlas, fluorescence was measured
along anterior-posterior axis based on the localization of bregma using NIH Image J software
(Figure 2a). The mean integrated optical density (MIOD) of TRd3 at a total of 80 sites were sequen-
tially measured from 4 mm anterior to 8 mm posterior to the bregma. In addition, the telencephalon
from five mice per genotype was cut into 100 mm coronal sections using a vibratome (Leica, Wetzlar,
Germany). Sections were mounted on gelatin-coated slides, washed, and cover-slipped with the sli-
ces coated in PBS/glycerol. Images of 6–8 coronal sections collected sequentially from 1.7 mm ante-
rior to 0.7 mm posterior of the bregma were imaged by a Leica DM4000B digital microscope (Leica
Microsystems, Wetzlar, Germany) under a 1.25x objective, with uniform exposure time, offset, and
gain. The distribution of the tracer (TRd3) was quantified using NIH Image J software as described
previously (Iliff et al., 2012). In brief, the fluorescent tracer coverage within the whole section was
detected using the same threshold and constant settings for minimum and maximum intensities.
Subregional analysis of CSF tracer distribution was analyzed in coronal section at the level of 0.5 mm
anterior to the bregma. Tracer penetration along perivascular spaces and into brain parenchyma was
quantified on high-magnification images of the hypothalamus, which were captured with 10x objec-
tive. The fluorescence intensity within the perivascular space was measured along large vessels
(diameter >20 mm) extending 500 mm below the brain surface. Two or three separate vessels from
each image were analyzed and the data averaged. The fluorescence intensity in the brain paren-
chyma was also determined along a corresponding linear region adjacent to the vessels (Figure 2e).
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The imaging and subsequent analysis was performed by an investigator who was blind to animal
genotype.
RIKEN
Adult mice (postnatal 10 to 23 weeks old, mixed gender) were anesthetized by a ketamine-xylazine
cocktail (70 mg/kg of ketamine and 10 mg/kg of xylazine) and fixed to a stereotaxic frame. The
membrane of the cisterna magna was exposed by surgical procedures. A glass micropipette (tip
diameter ~50 mm, preloaded with 0.5% biotinylated dextran amine in saline (BDA, 70 kDa, D1957,
Molecular Probes), was carefully pierced through the cisterna magna membrane using a manipulator.
A total of 10 mL of the BDA containing solution was infused at a rate of 1 mL/min using a syringe
driver (KDS Legato Series, KD Scientific). Thereafter, two supplementary ketamine-xylazine adminis-
trations were made (30 min apart, 50% of the initial dose). Five minutes after the second supplemen-
tary anesthesia, Mice were transcardially perfused with fixative containing 4% paraformaldehyde in
0.1 M phosphate buffer. After one day of post-fixation in the same fixative, 60 mm slices were incu-
bated in 0.1% triton-X TBS containing Alexa-594-conjugated SA (1:1000) for one hour. Images of
SA-processed brain sections were acquired using a standard fluorescent microscope (Olympus BX51
equipped with a DP74 digital camera, Supplementary file 3). An offset, defined as the median of
the top 1% of pixel intensities of an unprocessed brain section, is subtracted from the raw image of
the SA-processed brain section. For depth profiles were calculated from the pial position of 3 mm
from the midline using ImageJ.
UNC
Intracisternal tracer injections
The experiments were performed as described previously (Iliff et al., 2012). In brief, mice (15–18
weeks old) were anesthetized with ketamine/xylazine (100/10 mg/kg) and then a cannula was surgi-
cally implanted into the cisterna magna (Xavier et al., 2018). Afterwards, an Alexa Fluor 647-conju-
gated bovine serum albumin tracer was infused into the cistern (0.5% in aCSF; 10 ml at 1 ml/min for
10 min) and allowed to circulate for 30 min. Body temperature was maintained throughout the
experiment. Perfusion-fixation is expected to alter intracranial pulsatility, a process that has been
shown to drive CSF flow (Iliff et al., 2013b); therefore, 30 min post-injection the mice were decapi-
tated, and the brain drop fixed in 4% PFA.
Tissue processing and microscopy
The mouse brains were post-fixed prior to sectioning. In brief, 100 mm thick coronal plane vibratome
sections were obtained using a Leica VT 1200S apparatus (Leica Biosystems, IL). Free-floating mouse
brain sections were mounted with ProLongTM Gold Antifade Mounting Media with DAPI (Life Tech-
nologies, CA). We used an epifluorescent macroscope for imaging mouse brain sections (Olympus,
Supplementary file 3). The images were pseudocolored and analyzed on FIJI software. The sections
were analyzed following methodology from both Iliff et al. (2012) and Smith et al. (2017). Mean
pixel intensity was calculated for six coronal sections covering +1.2 to  1.8 mm from anterior to pos-
terior relative to bregma. Subregional analysis of the coronal section at position +0.6 mm was con-
ducted to identify which regions accounted for the differences in CSF influx (Kress et al., 2014).
URMC
Intracisternal tracer injections
Mice (8- to 10-week-old males) were anesthetized with ketamine/xylazine (100/10 mg/kg) and fixed
in a stereotaxic frame whereupon the posterior atlanto-occipital membrane overlying the cisterna
magna was surgically exposed. For all CSF tracer experiments, Alexa 647-conjugated bovine serum
albumin (BSA-647; 66 kDa; 0.5%) was injected into the subarachnoid CSF via cisterna magna punc-
ture, at a rate of 1 or 2 mL/min for a period of five min (5 mL or 10 mL total volume) through a 30-
gauge syringe pump (Harvard Apparatus). To visualize penetration of fluorescent CSF tracers into
the brain parenchyma ex vivo, anesthetized animals were decapitated at 30 min after the start of the
injection, a time point previously identified to correspond to robust tracer penetration of similar
molecular weight compounds in young male C57BL/6 mice (Iliff et al., 2012). Brains were then
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removed and post-fixed in 4% PFA for 24 hr before being sliced with a vibratome into 100 mm coro-
nal sections which were slide-mounted using PROLONG anti-fade gold with DAPI (Invitrogen).
In vivo transcranial optical imaging
Transcranial optical imaging was performed in KX-anesthetized mice as recently described
(Plog et al., 2018). To prepare the mouse, the skin overlying the dorsal convexity was reflected and
afterwards the cisterna magna was cannulated as described above. Fluorescent CSF tracers Texas
Red 3 kDa dextran and BSA-647 (10 ml at 2 ml/ min, 0.5% in aCSF) were injected into the cisterna
magna and imaged using a fluorescent macroscope (MVX10, Olympus) using a PRIOR Lumen 1600-
LED light source and ORCA Flash 4.0 digital camera (Hamamatsu). The mouse’s head was stabilized
with ear bars using a customized stereotaxic frame and placed under the microscope stage. Imaging
was done at a 20x magnification and acquired in the far-red emission channel (647 nm). Due to high
scattering at the excitation/emission wavelength of the Texas Red 3 kDa dextran through the intact
skull this channel was not acquired. Images were collected every minute for 30 min following the
start of the injection. MetaMorph Basic imaging software was used for image acquisition (Molecular
Devices). The same exposure time (100 ms) was used throughout the experiment and between the
WT and KO groups. After 30 min, the brain was extracted and fixed as described below.
Intrastriatal tracer injections
KX-anesthetized mice were placed in a stereotaxic apparatus and the skin was opened to expose
the skull. Carefully, periosteum was removed and bregma was identified with a surgical microscope.
A burr hole was done with a hand-held drill on the coordinates AP:+0.5 DV:+3.0 LM:+2.0 mm from
bregma, using a 27G needle to break the meningeal layer. A pulled glass capillary (TW100-3, World
Precision Instruments) with a 12 mm tip diameter was introduced in the brain parenchyma. Once in
place, 20 nL of 0.5% Amyloid-b1-40 in aCSF (as a sham) was delivered in a perfusion rate of 4 nL/sec-
ond by a micropump (UMP3 UltraMicroPump with Micro4 controller, World Precision Instruments) as
done by Smith et al. Control mice did not receive an injection. The micropipette remained in place
for 5 min and then was very slowly withdrew, to avoid any possible backflow. If backflow was
observed, the animal was excluded from the experiment. Immediately after the capillary was
removed, a small amount of Kwik-Cast Sealant (KWIK-CAST, World Precision Instruments) was
applied to seal the site of injection. After 60 min, mice received an injection in cisterna magna with
BSA-647 (1% in aCSF) as descried above to evaluate glymphatic function.
Ex-vivo imaging of fluorescent CSF tracers
BSA-647 and TxRd 3 kDa dextran circulation along perivascular pathways and penetration into the
brain parenchyma was visualized by conventional fluorescence microscopy of 100 mm vibratome cor-
onal brain sections, as described previously (Iliff et al., 2012). For coronal section quantification, six
brain sections (per animal were imaged and analyzed by a blinded investigator using an Olympus
fluorescence macroscope (MVX10) under 20x magnification to generate whole-slice images (using
the MetaMorph software, Molecular Devices, Supp. File 3). High-magnification montage images of
coronal sections were acquired using an Olympus BX51 fluorescent microscope at 4x objective mag-
nification using cellSens software (Olympus). Tracer penetration was quantified using NIH Image J
software as described previously (Iliff et al., 2012). The first slice was collected at the beginning at
the anterior aspect of the corpus callosum, one section was collected every 500 mm apart until a total
of six sections had been collected for each animal. Fluorescence of the CSF tracer BSA-647 was mea-
sured in each slice as mean pixel intensity (MPI). The MPI from the six brain slices from each animal
were averaged to define CSF penetration within a single biological replicate. For the ipsilateral to
contralateral comparison, 3 to 5 slices from the injection site where selected from each mouse, and
their tracer penetration was quantified, averaged and analyzed by Wilcoxon rank-sum test using dif-
ferent ROIs for each hemisphere. A subset of brain slices were immunostained for AQP4 as previ-
ously described (Kress et al., 2014). Tracer penetration depth was evaluated using Fiji and Matlab.
A coronal section obtained from bregma from each mouse was used for the analysis. In the KO
mice, a 500 mm line was placed orthogonal to the cortical surface at the most dorsal position where
tracer could be found at the pial surface (Figure 5f). Tracer depth in the WT mice was measured at
the same position as the KO mouse despite there being more tracer spread over the dorsal convex-
ity. The line profile was normalized to the maximum fluorescence at the cortical surface (DF/Fmax).
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Tracer penetration depth was quantified as the distance at which Fmax was reduced by half (d1/2) sim-
ilar to Smith et al. (2017).
OHSU
Dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) of
glymphatic transport
Three- to 6-month-old mice were anesthetized with isoflurane, with induction at 3–5%. The posterior
atlanto-occipital membrane was exposed surgically. To enable the contrast injection during MRI
scanning, we used a pulled glass micropipette with trimmed end (external diameter of approxi-
mately. 016 mm) to perform the injection. The micropipette was fixed in place for the duration of
the imaging session with superglue. Gadoteridol (68 mM, osmotically adjusted), a contrast medium
was infused by syringe pump (Harvard Apparatus) at a rate of 500 nl/min for 20 min (10 ml total vol-
ume), with a 2 ml chase of saline.
MR imaging
CSF circulation was quantified by dynamic contrast-enhanced magnetic resonance imaging (DCE-
MRI). All imaging was performed using a Bruker-Biospec 11.75 T preclinical scanner equipped with a
20 mm I.D. quadrature RF volume-coil with a specially designed head holder (Supplementary file 3).
Heart rate, oxygen saturation and respiratory rate were monitored, and core temperature was main-
tained at 37˚C using a warm air temperature control system (SA Instruments). Upon placement of
the glass micropipette, isoflurane anesthesia was switched to ketamine-xylazine (100–10 mg/kg) for
the duration of the experiment. Consecutive T1 weighted 3D FLASH images were obtained at 10
min intervals (TR/TE 16/2.8 ms, flip angle 15˚, matrix 256  192192, 100  100100 mm resolu-
tion), for a total of 90 min. Injection was initiated after acquiring the first image. If no elevation in sig-
nal was detectable in the cortical or subcortical brain regions or the basal cistern within the first 30
min, the imaging session was aborted, and the animal was excluded from further analysis.
MR data analysis
Due to frequent occurrence of motion artifact during the last 30 min of acquisition (70–90 min), these
three time points were excluded from analysis, and those animals showing movement artifacts dur-
ing the first 60 min of acquisition were also excluded. Linear rigid body registration was used to spa-
tially align the image series to the baseline image (FSL). Regions of interest (ROIs) were drawn on a
coronal image slice best matching that depicted in Figure 6I, and mean intensity values were deter-
mined with FIJI software. Repeated measures two-way ANOVA with Sidak multiple comparisons cor-
rection was used to analyze the data. Multiple comparisons were used to determine the significance
of genotype differences at each time point.
Meta-analysis
Literature search
A review of the literature on PubMed and Google Scholar was conducted for all studies published to
date (November 2018) on global Aqp4 KO models in rodents.
Inclusion criteria:
Out of 6527 studies that were retrieved from the online search, only tracer studies that evaluated
fluid flow in the brain in Aqp4 KO versus wild-type controls were included.
Exclusion criteria
Studies were excluded if either mean, standard deviation, or sample size could not be extracted.
Studies that evaluated tracer transport in a disease model were also eliminated. Non-English studies
were not excluded. Only one study Binder et al. 2004 was excluded due to the inability to estimate
sample size (Binder et al., 2004). After exclusion, a total of 11 studies satisfied the selection criteria.
Five data sets from the present study (NMU, RIKEN, UNC, URMC) were also included.
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Data extraction
Means, standard deviations, and sample sizes for each experiment were extracted from the text
where possible. If exact numbers were not reported, we used graphical extraction using FIJI. When
standard error of the mean was reported, standard deviation was calculated using the square root of
the sample size. In cases where sample size was reported as a range, the lowest number was chosen
for analysis. In one study, it was impossible to determine if two separate analyses were derived from
the same group of mice. In order to avoid inadvertently excluding data (e.g. If the study was in fact
conducted in two separate sets of mice) we included both experimental data sets in the meta-
analysis (Smith et al., 2017).
Data analysis
Studies addressed mainly two parts of intracranial fluid flow: (1) CSF influx to brain after delivery of
tracers to the cisterna magna and (2) tracer transport after being injected into the interstitial fluid in
the brain parenchyma. To address these two types of experiments, we decided to run two separate
models using the inverse variance method for meta-analysis. Since these were evaluated using differ-
ent outcome measures between fluorescence (fluorescence intensity and thresholding approaches),
radioisotope, and MRI experiments we opted for a standardized mean difference (SMD) using the
Cohen’s D method for the final analysis. After data was extracted, analysis was done in R (R-Project).
Due to high heterogeneity (I2 >70%), a random effects model was selected after attempting to
reduce heterogeneity by implementing alternate standardized mean difference formulas (e.g. Glass’s
delta, Hedge’s G); however, these attempts did not eliminate heterogeneity. Sources of heterogene-
ity were then explored using mixed-effects model meta-regression. Candidate predictors of hetero-
geneity included: anesthesia type, species, strain, age, tracer properties, injection properties,
injection location, and experimental method. Inclusion of more than one covariate in the meta-
regression resulted in model non-convergence due to the relatively small number of studies and the
distribution of these factors across studies so covariates were included one at a time. Data in forest
plots is shown as SMD with 95% confidence intervals (CI) and p values less than 0.05 were consid-
ered significant.
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